SCHEMBL19974130

SCHEMBL19974130

Cc1ccccc1-c1cc(NC(=O)/C=C/C(=O)O)ccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.52
THRB P10828 1/20 0.52
LPAR1 Q92633 1/20 0.51
LPAR2 Q9HBW0 1/20 0.51
CREBBP Q92793 1/20 0.51
ALDH1A1 P00352 8/20 0.50
MAPT P10636 6/20 0.50
KDM4E B2RXH2 6/20 0.50
KMT2A Q03164 5/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
LPAR3 Q9UBY5 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PARP1 P09874 2/20 0.47
PARP15 Q460N3 2/20 0.47
PARP14 Q460N5 2/20 0.47
PARP10 Q53GL7 2/20 0.47
MEN1 O00255 3/20 0.47
NMT1 P30419 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19974131 1.00 PKM (0.52) PKMTHRBLPAR1LPAR2CREBBP
SCHEMBL30271567 0.85 LMNA (0.56) PKMTHRBALDH1A1MAPTKDM4E
SCHEMBL19981409 0.85 LMNA (0.56) PKMTHRBALDH1A1MAPTKDM4E
SCHEMBL23647318 0.83 ALDH1A1 (0.59) PKMTHRBLPAR1LPAR2CREBBP
SCHEMBL19974422 0.83 ALDH1A1 (0.59) PKMTHRBLPAR1LPAR2CREBBP
SCHEMBL19974201 0.80 NMT1 (0.60) LPAR1LPAR2CREBBPALDH1A1MAPT
SCHEMBL19974204 0.80 NMT1 (0.60) LPAR1LPAR2CREBBPALDH1A1MAPT
SCHEMBL19974172 0.78 ALDH1A1 (0.60) THRBLPAR1LPAR2CREBBPALDH1A1
SCHEMBL19974174 0.78 ALDH1A1 (0.60) THRBLPAR1LPAR2CREBBPALDH1A1
SCHEMBL19974536 0.76 ALDH1A1 (0.55) THRBLPAR1LPAR2CREBBPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512602-B1 INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF HSF PHARMACEUTICALS (CH) 2024-03-27 EP disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
EP-3512602-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF Pharmaceuticals (CH) 2019-07-24 EP disclosed
WO-2018050656-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF PHARMACEUTICALS (CH) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 PKM 3069/4885THRB 1899/4885LPAR1 4587/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 PKM 3069/4885THRB 1899/4885LPAR1 4587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.